Cargando…

Population Pharmacokinetics of Tigecycline: A Systematic Review

Although tigecycline is widely used in clinical practice, its efficiency and optimal dosage regimens remain controversial. The purpose of this article was to help guide tigecycline dosing in different patient subpopulations through comparing the published population pharmacokinetic models of tigecyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Can-Can, Huang, Fang, Zhang, Jing-Ming, Zhuang, Yu-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211078/ https://www.ncbi.nlm.nih.gov/pubmed/35747442 http://dx.doi.org/10.2147/DDDT.S365512

Ejemplares similares

Population pharmacokinetics of tigecycline in critically ill patients
por: Luo, Xiangru, et al.
Publicado: (2023)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock
por: Borsuk-De Moor, Agnieszka, et al.
Publicado: (2018)

Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
por: Broeker, A., et al.
Publicado: (2018)

The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
por: Rypulak, E, et al.
Publicado: (2015)

Comparative pharmacokinetics of chlortetracycline, tetracycline, minocycline, and tigecycline in broiler chickens
por: Ziółkowski, Hubert, et al.
Publicado: (2020)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
por: Wang, Jian, et al.
Publicado: (2017)

Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
por: De Pascale, Gennaro, et al.
Publicado: (2020)

The Pharmacokinetics/Pharmacodynamics and Neurotoxicity of Tigecycline Intraventricular Injection for the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Intracranial Infection
por: Huang, Qi, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Target Attainment of Tigecycline in Patients with Hepatic Impairment in a Real-World Setting
por: Yang, Xiaoxuan, et al.
Publicado: (2023)

Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
por: Kipourou, Maria, et al.
Publicado: (2023)

Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review
por: Liu, Yang-Xi, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Tigecycline in 67 Infected Patients and a Population Pharmacokinetics/Microbiological Evaluation of A. baumannii Study
por: Yang, Tianli, et al.
Publicado: (2021)

Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
por: Zha, Lei, et al.
Publicado: (2020)

Population Pharmacokinetics of Clozapine: A Systematic Review
por: Albitar, Orwa, et al.
Publicado: (2020)

Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection
por: Yu, Meiling, et al.
Publicado: (2023)

Population pharmacokinetics of polymyxin B: a systematic review
por: Chen, Na, et al.
Publicado: (2022)

Genetic Determinants of Tigecycline Resistance in Mycobacteroides abscessus
por: Ng, Hien Fuh, et al.
Publicado: (2022)

Influence of continuous renal replacement therapy on the plasma concentration of tigecycline in patients with septic shock: A prospective observational study
por: Huang, Fang, et al.
Publicado: (2023)

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae
por: Sun, Lilan, et al.
Publicado: (2022)

Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review
por: Yaghoubi, Sajad, et al.
Publicado: (2021)

First Emergence of acrAB and oqxAB Mediated Tigecycline Resistance in Clinical Isolates of Klebsiella pneumoniae Pre-Dating the Use of Tigecycline in a Chinese Hospital
por: Zhong, Xue, et al.
Publicado: (2014)

Acute pancreatitis caused by tigecycline: A case report and literature review
por: Wang, Peng-fei, et al.
Publicado: (2021)

Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis
por: Ni, Wentao, et al.
Publicado: (2016)

Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects
por: Gotfried, Mark H., et al.
Publicado: (2017)

A Review of Population Pharmacokinetic Models of Posaconazole
por: Ding, Qin, et al.
Publicado: (2022)

The Rapid Emergence of Tigecycline Resistance in bla(KPC–2) Harboring Klebsiella pneumoniae, as Mediated in Vivo by Mutation in tetA During Tigecycline Treatment
por: Du, Xiaoxing, et al.
Publicado: (2018)

Factors Influencing Pharmacokinetics of Tamoxifen in Breast Cancer Patients: A Systematic Review of Population Pharmacokinetic Models
por: Dilli Batcha, Jaya Shree, et al.
Publicado: (2022)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023)

Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli
por: Sun, Jian, et al.
Publicado: (2019)

Pharmacokinetics of Clavulanic Acid in the Pediatric Population: A Systematic Literature Review
por: Keij, Fleur M., et al.
Publicado: (2022)

A Systematic Review on the Clinical Pharmacokinetics of Cephalexin in Healthy and Diseased Populations
por: Kanan, Mohammed, et al.
Publicado: (2023)

Emergence of tigecycline resistance in Escherichia coli co-producing MCR-1 and NDM-5 during tigecycline salvage treatment
por: Wang, Qian, et al.
Publicado: (2018)

Tigecycline Induced Hyperpigmentation of the Skin
por: Vandecasteele, S. J., et al.
Publicado: (2016)

Tigecycline-Induced Severe Hypoglycemia in a Non-Diabetic Individual: A Case Report and Brief Review of Tigecycline-Induced Severe Hypoglycemia
por: Ray, Avik, et al.
Publicado: (2020)

Risk Factors for Tigecycline-Associated Hypofibrinogenemia
por: Liu, Jia, et al.
Publicado: (2021)

Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia
por: Townsend, Mary L, et al.
Publicado: (2011)

Biological Functions and Molecular Mechanisms of Antibiotic Tigecycline in the Treatment of Cancers
por: Dong, Zhen, et al.
Publicado: (2019)

Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004–2013
por: Hoban, Daryl J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o77dk7nctu5jsu9o36ua7b1s02